Avenue Therapeutics
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Established
- 2015-01-01
- Employees
- 3
- Market Cap
- -
- Website
- http://www.avenuetx.com
- Introduction
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty
- Conditions
- Interventions
- First Posted Date
- 2018-12-13
- Last Posted Date
- 2019-05-09
- Lead Sponsor
- Avenue Therapeutics, Inc.
- Target Recruit Count
- 360
- Registration Number
- NCT03774836
- Locations
- ๐บ๐ธ
Lotus Clinical Research, Pasadena, California, United States
๐บ๐ธHermann Drive Research, Houston, Texas, United States
๐บ๐ธEndeavor Clinical Trials, San Antonio, Texas, United States
Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery
- First Posted Date
- 2018-01-10
- Last Posted Date
- 2021-03-09
- Lead Sponsor
- Avenue Therapeutics, Inc.
- Target Recruit Count
- 251
- Registration Number
- NCT03395808
- Locations
- ๐บ๐ธ
Lotus Clinical Research, Pasadena, California, United States
Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy
- First Posted Date
- 2017-09-21
- Last Posted Date
- 2020-03-19
- Lead Sponsor
- Avenue Therapeutics, Inc.
- Target Recruit Count
- 409
- Registration Number
- NCT03290378
- Locations
- ๐บ๐ธ
Lotus Clinical Research, Pasadena, California, United States
๐บ๐ธH.D. Research Corporation, Houston, Texas, United States
๐บ๐ธTrovare Clinical Research, Bakersfield, California, United States